United Kingdom: Biotechnology and Other New Production Technologies Annual
The first half of 2025 saw the United Kingdom (UK) progressed on two main items related to biotechnology, it (1) adopted secondary legislation needed to implement the Precision Breeding Act, (2) streamlined the market authorization process for Genetically Engineered (GE) regulated products. On the other hand, the UK made no new GE authorizations since the 2024 Biotech Annual report. Consequently, Great Britain (GB) has fallen further behind the European Union (EU) in its GE authorizations, with the backlog now standing at 28 GE events, despite the removal of the requirement for ten-yearly renewals in GB in March 2025. Additionally, the prospect of the UK entering a new Sanitary & Phytosanitary (SPS) deal with the EU appears to have placed any other changes by the UK in biotechnology on hold.